InnoGene Co Rendement FCF

Que fait InnoGene Co ? InnoGene Co Ltd is a company based in Seoul, South Korea, operating within the Consumer Staples sector and the Consumer products industry. The company has 77 employees and went public on April 27, 2020. Its website is http://www.innogene.com/. InnoGene focuses on research and development related to skin regeneration and anti-aging solutions, utilizing stem cell technology and fusion technology. The company develops and manufactures cosmetics aimed at skin regeneration and aging control. Additionally, InnoGene is involved in the manufacturing and distribution of medical devices. The company's primary activities revolve around creating products that address skin health and aging concerns, leveraging scientific research in stem cell applications. As a publicly traded entity, InnoGene operates under the ticker symbol 344860.KQ and is registered with the ISIN KR7344860002. The company's headquarters are located in Seoul, and it serves a market that values innovative skincare and medical device solutions. InnoGene's product portfolio includes both cosmetic and medical device offerings, targeting consumers interested in advanced skincare technologies. The company's operations are centered on research-driven development to enhance skin health and combat aging effects. InnoGene Co est l'une des entreprises les plus populaires sur Eulerpool.